Alternative potential mechanisms underlying GLP-1 RAs’ effects in dementia are through inflammatory and cerebrovascular factors; neuroinflammation is a key driver of AD pathology18 with GLP-1 RAs having been shown to regulate both systemic19 and neuroinflammation.20 This evidence concerns the gene GCG and Alzheimer disease.